It has been reported that blocking of HMG-CoA reductase with statins can affect the expression of CD20 on lymphoma cell lines and primary lymphoma cells [41] and the consequent ADCC triggered with the humanized antibody rituximab. Here, HMGCR is linked to lymphoma.